Volume 133, Issue 1, Pages (July 2007)

Slides:



Advertisements
Similar presentations
Volume 133, Issue 1, Pages (July 2007)
Advertisements

Volume 141, Issue 5, Pages e1 (November 2011)
Renin-stimulated TGF-β1 expression is regulated by a mitogen-activated protein kinase in mesangial cells  Y. Huang, N.A. Noble, J. Zhang, C. Xu, W.A.
Volume 131, Issue 4, Pages (October 2006)
Volume 144, Issue 3, Pages e4 (March 2013)
Volume 145, Issue 2, Pages (August 2013)
Volume 133, Issue 6, Pages (December 2007)
Volume 127, Issue 2, Pages (August 2004)
Volume 132, Issue 5, Pages (May 2007)
Volume 133, Issue 2, Pages (August 2007)
Volume 131, Issue 2, Pages (August 2006)
Volume 128, Issue 1, Pages (January 2005)
Volume 137, Issue 2, Pages e2 (August 2009)
Volume 141, Issue 5, Pages e1 (November 2011)
Volume 128, Issue 3, Pages (March 2005)
Volume 136, Issue 3, Pages e2 (March 2009)
PTF1α/p48 and cell proliferation
Volume 132, Issue 3, Pages (March 2007)
Volume 133, Issue 6, Pages (December 2007)
Volume 132, Issue 1, Pages (January 2007)
Prolyl Hydroxylase-3 Is Down-regulated in Colorectal Cancer Cells and Inhibits IKKβ Independent of Hydroxylase Activity  Jing Xue, Xuebing Li, Shi Jiao,
Volume 141, Issue 6, Pages (December 2011)
Volume 134, Issue 5, Pages (May 2008)
Making Sense of HDAC2 Mutations in Colon Cancer
Volume 16, Issue 4, Pages (October 2009)
Volume 136, Issue 5, Pages (May 2009)
Volume 131, Issue 4, Pages (October 2006)
Volume 136, Issue 2, Pages (February 2009)
Volume 138, Issue 5, Pages e3 (May 2010)
Volume 130, Issue 7, Pages (June 2006)
Sp1 Is Required for Glucose-Induced Transcriptional Regulation of Mouse Vesicular Glutamate Transporter 2 Gene  Tao Li, Liqun Bai, Jing Li, Suzu Igarashi,
Renin-stimulated TGF-β1 expression is regulated by a mitogen-activated protein kinase in mesangial cells  Y. Huang, N.A. Noble, J. Zhang, C. Xu, W.A.
PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation
Volume 140, Issue 4, Pages e1 (April 2011)
Volume 142, Issue 3, Pages e2 (March 2012)
Volume 131, Issue 4, Pages (October 2006)
Volume 114, Issue 6, Pages (June 1998)
Volume 145, Issue 2, Pages (August 2013)
Volume 133, Issue 4, Pages (October 2007)
Volume 132, Issue 4, Pages (April 2007)
Volume 137, Issue 1, Pages (July 2009)
Dongmei Ye, Shuhong Guo, Rana Al–Sadi, Thomas Y. Ma  Gastroenterology 
Volume 136, Issue 4, Pages (April 2009)
Epidermal Growth Factor Receptor–Mediated Proliferation of Enterocytes Requires p21waf1/cip1 Expression  George Sheng, Kathryn Q. Bernabe, Jun Guo, Brad.
Hsueh Yang, Gabrielle Curinga, Cecilia M. Giachelli 
Volume 129, Issue 5, Pages (November 2005)
PPARβ/δ Activation Induces Enteroendocrine L Cell GLP-1 Production
Volume 125, Issue 1, Pages (July 2003)
Decreased expression of FOXA2 promotes eutopic endometrial cell proliferation and migration in patients with endometriosis  Anping Lin, Juan Yin, Chao.
Volume 62, Issue 3, Pages (September 2002)
Volume 62, Issue 1, Pages (July 2002)
Volume 136, Issue 3, Pages (March 2009)
Volume 153, Issue 5, Pages e3 (November 2017)
P. Harding, L. Balasubramanian, J. Swegan, A. Stevens, W.F. Glass 
A Novel Role of Transforming Growth Factor β1 in Transcriptional Repression of Human Cholesterol 7α-Hydroxylase Gene  Tiangang Li, John Y.L. Chiang  Gastroenterology 
Inducible Nitric Oxide Synthase Up-Regulates Notch-1 in Mouse Cholangiocytes: Implications for Carcinogenesis  Norihisa Ishimura, Steven F. Bronk, Gregory.
Volume 133, Issue 4, Pages (October 2007)
Volume 128, Issue 7, Pages (June 2005)
Volume 16, Issue 12, Pages (June 2006)
Volume 134, Issue 1, Pages (January 2008)
Volume 127, Issue 4, Pages (October 2004)
BMP-4 Upregulates Kit Expression in Mouse Melanoblasts prior to the Kit-Dependent Cycle of Melanogenesis  Tamihiro Kawakami, Satoko Kimura, Yoko Kawa,
Volume 128, Issue 7, Pages (June 2005)
Volume 116, Issue 2, Pages (February 1999)
Volume 60, Issue 3, Pages (September 2001)
Volume 18, Issue 3, Pages (March 2010)
Regulation of human renin gene promoter activity: A new negative regulatory region determines the responsiveness to TNFα  Ling-Sing K. Chen, Michael P.
Bcl-2 and bcl-xL Antisense Oligonucleotides Induce Apoptosis in Melanoma Cells of Different Clinical Stages  Robert A. Olie, Christoph Hafner, Renzo Küttel,
Volume 56, Issue 3, Pages (September 1999)
The human colonic monocarboxylate transporter Isoform 1: Its potential importance to colonic tissue homeostasis  Mark Cuff, Jane Dyer, Mark Jones, Soraya.
Presentation transcript:

Volume 133, Issue 1, Pages 207-218 (July 2007) Role of Methionine Adenosyltransferase 2A and S-adenosylmethionine in Mitogen- Induced Growth of Human Colon Cancer Cells  Hui Chen, Meng Xia, Mark Lin, Heping Yang, John Kuhlenkamp, Tony Li, Nicole M. Sodir, Yong–Heng Chen, Heinz Josef–Lenz, Peter W. Laird, Steven Clarke, José M. Mato, Shelly C. Lu  Gastroenterology  Volume 133, Issue 1, Pages 207-218 (July 2007) DOI: 10.1053/j.gastro.2007.03.114 Copyright © 2007 AGA Institute Terms and Conditions

Figure 1 Steady-state MAT II protein levels in colon cancer and HT-29 cells treated with IGF-1. Human colon cancer specimens (CA; CA-1 is patient 12 and CA-2 is patient 13 in Table 1) and matched normal colon tissues (NL), and HT-29 cells treated with IGF-1 (100 ng/mL for 8 hours), were processed for Western blot analysis as described in Materials and Methods using 40 μg protein/lane. Densitometric changes (% of NL or control) are shown below each blot. Gastroenterology 2007 133, 207-218DOI: (10.1053/j.gastro.2007.03.114) Copyright © 2007 AGA Institute Terms and Conditions

Figure 2 Effects of leptin, IGF-1, and EGF on expression of MAT genes in RKO and HT-29 cells. (A) RKO cells were treated with leptin (100 ng/mL) for 1–24 hours, and MAT2A and MAT2β mRNA levels were measured using real-time PCR as described in Materials and Methods. (B) RKO cells were treated with leptin (100 ng/mL, 6 hours), IGF-1, or EGF (both at 100 ng/mL, 3 hours), and MAT2A mRNA levels were measured as in A. (C) HT-29 cells were treated with leptin as in A. All results represent mean ± SEM from 3 independent experiments performed in duplicate. *P < .05 vs control. Gastroenterology 2007 133, 207-218DOI: (10.1053/j.gastro.2007.03.114) Copyright © 2007 AGA Institute Terms and Conditions

Figure 3 SAMe and MTA (A) lower MAT2A mRNA levels and (B) prevent a growth factor–induced increase in MAT2A expression. HT-29 cells were treated with SAMe (5 mmol/L) or MTA (1 mmol/L) or vehicle control for 3–6 hours, and MAT2A mRNA levels were determined by real-time PCR (A). To examine whether SAMe and MTA can modulate the effect of the growth factors on MAT2A expression, HT-29 cells were treated with growth factors SAMe or MTA alone or in combination. Cotreatment of SAMe or MTA with leptin was for 6 hours, while cotreatment for IGF-1 or EGF was for 3 hours. All results represent mean ± SEM from 3–4 independent experiments performed in duplicate. *P < .05 vs control, †P < .05 vs respective growth factors. Gastroenterology 2007 133, 207-218DOI: (10.1053/j.gastro.2007.03.114) Copyright © 2007 AGA Institute Terms and Conditions

Figure 4 Effect of IGF-1, EGF, leptin, SAMe, and MTA treatment on luciferase activity driven by the human MAT2A promoter. HT-29 cells were transfected transiently with the human MAT2A promoter construct –571/+60-LUC or pGL-3 enhancer vector and treated with IGF-1 (100 ng/mL, 3 hours), EGF (100 ng/mL, 3 hours), leptin (100 ng/mL, 6 hours), SAMe (5 mmol/L, 6 hours), MTA (1 mmol/L, 6 hours), or vehicle control. Cells were cotransfected with Renilla luciferase for control of transfection efficiency. Results represent mean ± SEM from 3 independent experiments performed in triplicate. Data are expressed as relative luciferase activity to that of pGL-3 enhancer vector control, which is assigned a value of 1.0. *P < .05 vs. –571/+60-LUC construct control. Gastroenterology 2007 133, 207-218DOI: (10.1053/j.gastro.2007.03.114) Copyright © 2007 AGA Institute Terms and Conditions

Figure 5 Effects of SAMe, MTA, EGF, IGF-1, and leptin on cell growth. HT-29 cells were treated with various growth factors, SAMe (0.5–5 mmol/L), and MTA (0.5–1 mmol/L) alone or in combination for 16 hours for cell growth determination by the MTT assay as described in Materials and Methods. Results represent mean ± SEM from 3 independent experiments performed in triplicate. *P < .05 vs control, †P < .05 vs respective growth factors. Gastroenterology 2007 133, 207-218DOI: (10.1053/j.gastro.2007.03.114) Copyright © 2007 AGA Institute Terms and Conditions

Figure 6 MAT2A RNAi#1 causes a profound decrease in MAT2A mRNA level and increased apoptosis. RKO cells were treated with MAT2A RNAi#1, and MAT2A mRNA levels were determined up to 48 hours after treatment (A). Apoptosis was determined by Hoechst staining after (B) 24 hours and (C) 48 hours of RNAi#1 treatment. Full time course study of RNAi#1 on MAT2A expression was performed in triplicate in 1 experiment, and apoptosis was determined in 3 separate experiments. *P < .05 vs scrambled. Gastroenterology 2007 133, 207-218DOI: (10.1053/j.gastro.2007.03.114) Copyright © 2007 AGA Institute Terms and Conditions

Figure 7 Effect of MAT2A RNAi#5 on MAT2A mRNA levels and cell growth in response to growth factors. (A) HT-29 cells were treated with RNAi#5 or scrambled (SC) RNAi control for 48 hours, and then growth factors were added for either 3 hours (IGF-1, EGF) or 6 hours (leptin) at 100 ng/mL. MAT2A mRNA levels were measured by real-time PCR. (B) HT-29 or RKO cells were treated with RNAi#5 or SC control for 48 hours, followed by addition of growth factors or vehicle control for another 24 hours for the MTT assay. *P < .05 vs control, †P < .05 vs RNAi#5 and respective growth factors from 3 experiments. Gastroenterology 2007 133, 207-218DOI: (10.1053/j.gastro.2007.03.114) Copyright © 2007 AGA Institute Terms and Conditions

Figure 8 Stability of SAMe and MTA in culture medium at 37°C. (A) SAMe and (B) MTA levels were measured as described in Materials and Methods in culture medium without cells with starting SAMe concentrations ranging from 1 to 5 mmol/L and MTA concentration at 1 mmol/L. Gastroenterology 2007 133, 207-218DOI: (10.1053/j.gastro.2007.03.114) Copyright © 2007 AGA Institute Terms and Conditions

Figure 9 Methionine, SAMe, and polyamine metabolism in cellular growth pathways. The production of polyamines, required for growth and differentiation, is dependent on intracellular SAMe. In nonhepatic cells, SAMe is made by MAT2A-encoded MAT II. We show here that MAT2A is induced by mitogens, including EGF, IGF-1, and leptin, which provide an increase in SAMe source for polyamine synthesis. When cells are incubated with extracellular SAMe, growth can be affected by several possible mechanisms. If SAMe can be transported into cells, it can inhibit the activity of MAT II by product inhibition. SAMe can also be spontaneously converted into MTA, which is known to be rapidly transported into cells. The resulting increased intracellular levels of MTA can inhibit the formation of polyamines by product inhibition. Plus symbols indicate activation of a step; minus symbols indicate inhibition. Gastroenterology 2007 133, 207-218DOI: (10.1053/j.gastro.2007.03.114) Copyright © 2007 AGA Institute Terms and Conditions